Merck & Co., Inc.

Merck & Co., Inc.

Merck & Co., Inc.

Overview
Date Founded

1891

Headquarters

2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA

Type of Company

Public

Employees (Worldwide)

71K

Industries

Pharmaceuticals
Medical Support Services
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Biotechnology

Company Description

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Contact Data
Trying to get in touch with decision makers at Merck & Co., Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, Global Services & Chief Financial Officer

Executive Vice President, General Counsel & Corporate Secretary

Executive Vice President & Chief Marketing Officer

Senior Vice President, Human Resources

Executive Vice President & Chief Commercial Officer

Chief Information & Digital Officer

Chief Medical Officer

Executive Vice President & Chief Human Resources Officer

Board of Directors

Chief Executive Officer at Merck & Co., Inc.

Chairman of the Board, President & Chief Executive Officer at Northrop Grumman Corp.

Executive Chairman at 3M Interamerica, Inc.

Former Managing Partner of Global Business Operations at Accenture Plc

Chairman & Chief Executive Officer at SARR Group LLC

Penn Integrates Knowledge Professor of Population Health & Health Equity at University of Pennsylvania - School of Nursing

Executive Chairman & Founder at BlueVoyant LLC

Former Chief Executive Officer at Nokia of America Corp.

Director-Cardiovascular Genetics Center at The Brigham & Women's Hospital, Inc.

Founder & Advisor at Sierra Ventures

Paths to Merck & Co., Inc.
Potential Connections via
Relationship Science
You
Merck & Co., Inc.
Owners & Shareholders
Details Hidden

The Vanguard Group is an American investment management company based in Malvern, Pennsylvania, that manages approximately $3.4 trillion[1] in assets. It is the largest provider of mutual funds and now the second-largest provider of exchange-traded funds (ETFs) in the world after BlackRock, with about $451 billion in ETF assets under management, as of March 2015.[3] It offers mutual funds and other financial products and services to retail and institutional investors in the United States and abroad. Founder and former chairman John C. Bogle is credited with the creation of the first index fund available to individual investors,[4] the popularization of index funds generally,[5] and driving costs down across the mutual fund industry.

Details Hidden

SSgA FM’s methods of analysis include quantitative, fundamental, technical, cyclical, indexing, arbitrage, charting and other strategy specific methods. They offer a broad range of strategies including: Active, Enhanced, and Passive Equity; Active & Passive Debt; Cash Management; Multi-Asset Class Solutions; Real Estate (including Direct Real Estate); Senior Loans; Managed Futures; and Private Equity. Active equity strategies include enhanced equity and active quantitative strategies. The strategies cover market-cap and style segments of the market including: large-cap core, large-cap growth, large-cap value, mid-cap, small-cap, small-cap value, all-cap, and long-short equity. They also manage long-short and long-short market neutral strategies. SSgA FM’s Active & Passive Debt strategies offers a range of investment styles from passive to active, short to long duration, tax-exempt, sovereign to high yield, and single country to global. The firm’s Cash Management strategies seek to generate current income while preserving capital and liquidity by investing in diversified portfolios of short-term securities. SSgA FM's Multi-Asset Class strategies employ an asset allocation model as means of diversification and seek to position assets among major investment categories. Their Multi Asset Class Solutions strategies employ an asset allocation model as a method of diversification that aims to position assets among major investment categories. SSgA FM’s Managed Futures strategy allocates assets using two approaches: a managed futures strategy and a fixed income strategy. The firm’s Private Equity strategies focus on rigorous partner selection, thorough evaluation of quality investment opportunities, and fundamental, research-driven research.

Details Hidden

BFA utilizes fixed-income strategies that are actively managed, model or index based. Actively managed fixed-income mandates generally employ an active investment style that emphasizes rotation among different types of debt on a relative value basis, specific security selection, quantitative analysis of each security and the portfolio as a whole and intensive credit analysis and review. They utilize a risk-controlled, systematic process for portfolio construction and alpha generation. Alpha sources may include security selection, duration and yield curve positioning, industry rotation, asset allocation, and currency positioning. BFA's equity platform includes a broad range of products that vary according to investment style (active, scientific and passive management), market-cap (small-, mid-, small/mid-, large- and all-cap), and geography (global, international and regional). The product range may also include sector funds, long-only and long-short portfolios, as well as products that combine different strategies to create balanced and asset allocation portfolios. For cash management portfolios, the investment process emphasizes safety and liquidity over yield. Their alternative mandates focus on sourcing and managing high-alpha investments with lower correlation to public markets and developing a holistic approach to address client needs in alternatives investing.

Recent Transactions
Details Hidden

Merck & Co., Inc. purchases Themis Bioscience GmbH

Details Hidden

Fareva SA purchases Msd France SAS /Drug Prodcution Activity from Merck & Co., Inc.

Details Hidden

WebMD Health Corp., MH Sub I LLC purchase The StayWell Co. LLC from Merck & Co., Inc., Vestar Capital Partners, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Investment Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Legal Advisor

Advised onMerck & Co., Inc. purchases Schering-Plough Corporation

Advisors & Consultants
Legal Advisor

Senior Vice President, General Counsel & Secretary at General Electric Company

Advisor

Chairman & Chief Executive Officer at MDC Partners, Inc.

Legal Advisor

Partner at Jones Day

Clients

Henry Schein, Inc., a FORTUNE 500® company and a member of the NASDAQ 100® Index, is the largest provider of health care products and services to medical, dental, and veterinary office-based practitioners. The Company is one of Fortune Magazine's "World’s Most Admired Companies", and is ranked number 1 in its industry in social responsibility and global competitiveness. Now more than ever, health care providers require specialized products and services to operate their practices efficiently. We offer an extensive selection of dental supplies, medical supplies, pharmaceuticals, vaccines, equipment, software technology, and much more. Our portfolio of practice solutions is designed to support our customers and to successfully meet their business goals and achieve optimal patient satisfaction

Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded by Benjamin J. Shaw in 2014 and is headquartered in Portland, ME.

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Founder at Intellia Therapeutics, Inc.

Key Stats and Financials As of 2019
Market Capitalization
$203B
Total Enterprise Value
$252B
Earnings Per Share
$3.82
Revenue
$46.6B
Net Profit
$9.84B
EBITDAMargin
36.46%
Enterprise Value / Sales
5.4x
Enterprise Value EBITDAOperating
14.76x
TEVNet Income
25.57x
Debt TEV
0.11x
Total Equity
$26B
EBITDA
$17B
Total Debt
$27.4B
Three Year Compounded Annual Growth Rate Of Revenue
5.66%
Non-Profit Donations & Grants
$1 - $499
2019
$1,000 - $4,999
2019
Political Donations
$1,000
2014
$1,000
2014
$500
2014
Investments
Details Hidden

Just Biotherapeutics, Inc. operates as biotechnology firm. Its products include biosimilars and novel and repositioned biologics. The firm also offers molecular design, process and product platform and manufacturing and plant design services. The company was founded by James N. Thomas, Victor P. Fung, Dean K. Pettit, and Yining Zhao in 2014 and is headquartered in Seattle, WA.

Details Hidden

Yumanity Therapeutics, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA.

Details Hidden

HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA.

Investors
Details Hidden

Investor at Avid Radiopharmaceuticals, Inc.

Suppliers
Codexis, Inc. Chemicals | Redwood City, CA

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Johnson & Johnson Personal Products | New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bayer AG Medical Support Services | Leverkusen, Deu

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Awards & Honors
Rank #72
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #72
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Merck & Co., Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Merck & Co., Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Merck & Co., Inc..